Sinpas Gayrimenkul Yatirim Ortakligi A.S. (IST:SNGYO)
Turkey · Delayed Price · Currency is TRY 4.470
+0.010 (0.22%)
Last updated: Aug 13, 2025
Ligand Pharmaceuticals Revenue
Sinpas Gayrimenkul Yatirim Ortakligi A.S. had revenue of 1.08B TRY in the quarter ending March 31, 2025, a decrease of -42.58%. This brings the company's revenue in the last twelve months to 12.64B, up 234.15% year-over-year. In the year 2024, Sinpas Gayrimenkul Yatirim Ortakligi A.S. had annual revenue of 13.44B with 443.78% growth.
Revenue (ttm)
12.64B
Revenue Growth
+234.15%
P/S Ratio
1.41
Revenue / Employee
67.22M
Employees
205
Market Cap
17.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13.44B | 10.97B | 443.78% |
| Dec 31, 2023 | 2.47B | 100.72M | 4.25% |
| Dec 31, 2022 | 2.37B | 246.62M | 11.61% |
| Dec 31, 2021 | 2.12B | 135.29M | 6.80% |
| Dec 31, 2020 | 1.99B | 275.45M | 16.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition